OpenEvidence
OpenEvidence is a medical AI platform for healthcare professionals, offering AI-powered search and a HIPAA-secure dialer for patient calls.
Secondary Market Price
Secondary Market Price
How OpenEvidence Measures Up
To help you manage your OpenEvidence equity, Prospect has run the company through our machine learning model.
Prospect Rating
Exit Risk
Funding Stage
Series C
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of OpenEvidence's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future OpenEvidence Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for OpenEvidence's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
OpenEvidence operates an AI-powered medical information platform used by healthcare professionals to access journal content, guidelines, and other medical information through natural-language search. The platform is an official content partner of publications including the New England Journal of Medicine and The Journal of the American Medical Association. According to the company, its user base includes more than 500,000 healthcare professionals each month. Founded in 2021, OpenEvidence launched during the Mayo Clinic Platform Accelerate program and is backed by investors including Sequoia and Google.
The company plans to expand from an information retrieval tool to a platform that supports the creation of new medical evidence, partly by providing feedback to organizations like the American Diabetes Association (ADA) on how guidelines are used. Recent announcements include partnerships to integrate content from the American Academy of Family Physicians (AAFP) and the American College of Emergency Physicians (ACEP). OpenEvidence also launched a HIPAA-secure application, OpenEvidence Dialer, which allows clinicians to call patients from their personal devices while displaying their hospital's caller ID and generating clinical notes from the calls.
- Sequoia Capital
- Google Ventures
- Kleiner Perkins
- Coatue
- Thrive Capital
- Conviction
- ICONIQ
- Greycroft
- Breyer Capital
- Mayo Clinic
- Blackstone
- BOND
- Craft
- [Founder title], [Executive Title] Daniel Nadler
- [Founder title], [Executive Title] Zachary Ziegler
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is OpenEvidence worth joining?
Whether OpenEvidence is worth joining depends on your personal career goals and the specifics of the compensation package offered. A platform like Prospect can help you evaluate the potential future value of your equity offer to make a more informed decision.
What should I do with my OpenEvidence stock?
The best strategy for your OpenEvidence stock depends on your personal financial goals, risk tolerance, and tax situation. Using a service like Prospect can help you create a personalized plan for exercising options, managing taxes, and deciding when to sell.
Can you sell OpenEvidence stock?
As OpenEvidence is a private company, selling stock is typically restricted but may be possible during specific liquidity events like tender offers or on secondary markets. Tools like Prospect's tender offer tools can help you determine how much to sell and which shares are most tax-optimal for your situation.
How can I find the value of my OpenEvidence stock?
The value of private stock is not publicly listed and is often based on the company's latest 409A valuation or a recent funding round. You can use a platform like Prospect to forecast your equity's potential future value using their proprietary models and analysis of market data.
What is OpenEvidence's equity worth?
The precise worth of OpenEvidence's equity is not public information and changes based on factors like company performance and new funding rounds. To understand the potential post-tax value of your personal holdings, you can use an equity management platform like Prospect to model different financial scenarios.
What is OpenEvidence's stock ticker symbol?
As a private company, OpenEvidence does not have a stock ticker symbol because its shares are not available for trading on a public stock exchange. Ticker symbols are assigned only when a company completes an Initial Public Offering (IPO).
Can I buy or sell OpenEvidence stock?
Buying stock in a private company like OpenEvidence is generally limited to accredited investors during funding rounds, while selling is often restricted to company-approved events like tender offers. If you are an employee with equity, a platform like Prospect can help you navigate selling opportunities and optimize your decisions for taxes.
What is the criteria to buy or invest in OpenEvidence stock?
Investing in a private company like OpenEvidence is typically restricted to accredited investors, venture capital firms, and employees receiving equity compensation. The specific criteria for any investment opportunity would be defined by the company during a fundraising event or tender offer.
